CytomX Therapeutics, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | — | -164.6% | -164.4% |
| FY2022 | — | -194.7% | -190.8% |
| FY2023 | — | -6.4% | -0.6% |
| FY2024 | — | 18.1% | 23.1% |
| FY2025 | — | -29.3% | -22.8% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | — | -164.6% | -164.4% |
| FY2022 | — | -194.7% | -190.8% |
| FY2023 | — | -6.4% | -0.6% |
| FY2024 | — | 18.1% | 23.1% |
| FY2025 | — | -29.3% | -22.8% |